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Abstract
To comprehensively characterize the metabolic roles of crustacean hyperglycemic hormone
(CHH), metabolites in two CHH target tissues of the crayfish Procambarus clarkii, whose
levels were significantly different between CHH knockdown and control (saline-treated) ani-
mals, were analyzed using bioinformatics tools provided by an on-line analysis suite (Meta-
boAnalyst). Analysis with Metabolic Pathway Analysis (MetPA) indicated that in the muscle
Glyoxylate and dicarboxylate metabolism, Nicotinate and nicotinamide metabolism, Ala-
nine, aspartate and glutamate metabolism, Pyruvate metabolism, and Nitrogen metabolism
were significantly affected by silencing of CHH gene expression at 24 hours post injection
(hpi), while only Nicotinate and nicotinamide metabolism remained significantly affected at
48 hpi. In the hepatopancreas, silencing of CHH gene expression significantly impacted, at
24 hpi, Pyruvate metabolism and Glycolysis or gluconeogenesis, and at 48 hpi, Glycine, ser-
ine and threonine metabolism. Moreover, analysis using Metabolite Set Enrichment Analy-
sis (MSEA) showed that many metabolite sets were significantly affected in the muscle at
24hpi, including Ammonia recycling, Nicotinate and nicotinamide metabolism, Pyruvate
metabolism, Purine metabolism, Warburg effect, Citric acid cycle, and metabolism of sev-
eral amino acids, and at 48 hpi only Nicotinate and nicotinamide metabolism, Glycine and
serine metabolism, and Ammonia recycling remained significantly affected. In the hepato-
pancreas, MSEA analysis showed that Fatty acid biosynthesis was significantly impacted at
24 hpi. Finally, in the muscle, levels of several amino acids decreased significantly, while
those of 5 other amino acids or related compounds significantly increased in response to
CHH gene silencing. Levels of metabolites related to nucleotide metabolism significantly
decreased across the board at both time points. In the hepatopancreas, the effects were
comparatively minor with only levels of thymine and urea being significantly decreased at 24
hpi. The combined results showed that the metabolic effects of silencing CHH gene expres-
sion were far more diverse than suggested by previous studies that emphasized on carbo-
hydrate and energy metabolism. Based on the results, metabolic roles of CHH on the
muscle and hepatopancreas are suggested: CHH promotes carbohydrate utilization in the
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hepatopancreas via stimulating glycolysis and lipolysis, while its stimulatory effect on nicoti-
nate and nicotinamide metabolism plays a central role in coordinating metabolic activity in
the muscle with diverse and wide-ranging consequences, including enhancing the fluxes of
glycolysis, TCA cycle, and pentose phosphate pathway, leading to increased ATP supply
and elevated protein and nucleic acid turnovers.
1. Introduction
Crustacean hyperglycemic hormone (CHH) is a polypeptide hormone originally identified in
the X-organ/sinus gland (XO/SG) complex of the eyestalks [1–2]. Early biochemical studies of
CHHs isolated from various decapod crustaceans showed they are of 72–73 amino acid resi-
dues in length, with 3 disulfide bridges formed by 6 highly position-conserved cysteine resi-
dues [3–9]; peptide sequencing analyses indicated that CHH is N- and C-terminally blocked;
the C-terminal amide was found critical for its hyperglycemic activity [10–14]. These and sub-
sequent molecular studies [15–17] have established that CHH, being a prototypical member,
belong to a family of polypeptide hormones, the CHH family, which also includes molt-inhib-
iting hormone (MIH), vitellogenesis-inhibiting hormone (VIH), and mandibular organ-inhib-
iting hormone (MOIH), and insect ion transport peptide (ITP) [18–21].
Combined data indicated that CHH is functionally involved with regulation of carbohy-
drate metabolism and responsible for mediating stress-induced hyperglycemia [22–27]. Spe-
cially, glycogen mobilization in two CHH target tissues (the hepatopancreas and muscle) has
been shown to be stimulated by CHH (or tissue extracts containing CHH) through regulating
activity of the enzymes involved in glycogen metabolism [28–32]; other studies suggested that
CHH also stimulates glycolytic flux by increasing the availability of glycolysis substrate (glu-
cose) [22, 33].
In the previous study of ours [34], a double-stranded RNA (dsRNA) technique was
employed to effectively and specifically knock down CHH gene expression in the crayfish Pro-
cambarus clarkii. Metabolites in the tissue (the hepatopancreas and muscle) obtained from the
CHH dsRNA-injected (DSI) and saline injected (SAI) animals were detected, identified, and
quantified using a nuclear magnetic resonance (NMR)-based metabolomic method. Initial
analysis of metabolites directly related to carbohydrate and energy metabolism suggested that
CHH regulates tissue metabolism in tissue-specific and complementary manners [34]. In the
present study, to fully characterize the effects of silencing CHH gene expression and under-
stand the metabolic roles of CHH, we utilized web-based bioinformatics tools provided by
MetaboAnalyst to comprehensively analyze all tissue metabolites whose levels changed signifi-
cantly after CHH gene silencing. Results not only confirmed our previous conclusion that
CHH regulates carbohydrate and energy metabolism but also extended the scope of CHH reg-
ulatory roles to amino acid and nucleotides metabolism. Finally, a complete profile of CHH
metabolic function is presented and discussed.
2. Materials and methods
2.1 Ethics statement
All experiments using the crayfish (P. clarkii) were performed under the review committee of
National Changhua University of Education (Permit number: NCUE-1052900151), in full
accordance with the recommendations (Guidelines for Management and Use of Experimental
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Animals) set by the Council of Agriculture, Taiwan. Animals were purchased from local fisher-
men (Xihu River, Miaoli County, Taiwan), kept in freshwater tanks (water temperature:
24 ± 1˚C; photoperiod: 12L:12D), and fed commercial shrimp food (Shanghai Inc., Taiwan)
daily. Animals were anaesthetized with ice-cold water until immobile immediately before
dissection.
2.2 Experimental animals and experimental procedures
Experimental treatment protocol, efficacy and specificity of gene silencing by CHH dsRNA, as
well as NMR setting parameters, data acquisition and processing, and statistical analysis (Stu-
dent’s t-test) have been described in a previous study [34]. Briefly, double-stranded RNAs
were produced using an in vitro transcription reaction driven by T7 promoter and T7 RNA
Polymerase. Animals were treated with either saline injection (SAI) or CHH dsRNA injection
(CHH DSI), and, at designated time points (24, 48, 72 hours after treatment), tissues were dis-
sected under stereo-microscopes (SMZ745, Nikon) using fine scissors and used for a quantita-
tive real-time PCR (the eyestalk ganglia) or a dual phase extraction procedure (the muscle and
hepatopancreas). CHH dsRNA, but not green fluorescence protein dsRNA, effectively and sig-
nificantly decreased CHH gene expression in the eyestalk ganglia at the time points examined.
Aqueous phase extracts of the muscle and hepatopancreas were subjected to 1H Nuclear mag-
netic resonance (NMR) analysis (Varian Inova 500 MHz NMR spectrometer). The spectra
were analyzed using a commercial software package (Chenomx NMR suite 4.6, Chenomx,
Inc., Edmonton, Alberta, Canada) with the Chenomx 500-MHz (pH 6±8) library.
2.3 Metabolic Pathway Analysis (MetPA) and Metabolite Set Enrichment
Analysis (MSEA)
Tissue metabolites whose levels were significantly different between the SAI and CHH DSI
groups were subsequently analyzed using resources provided by a web-based tool suite Meta-
boAnalyst (v. 4.0, http://www.metaboanalyst.ca), specifically two functional analysis modules
—Metabolic Pathway Analysis (MetPA) and Metabolite Set Enrichment Analysis (MSEA) [39,
40]. Both approaches work by comparing the significant compounds identified from the data
uploaded by users to pre-defined functional groups [35].
MetPA combines statistical enrichment analysis with pathway topological characteristics to
identify the most relevant pathways under the study condition [36, 37]. Briefly, the metabolites
whose tissue levels were significantly different between SAI and CHH DSI groups were
uploaded. After data processing and compound name mapping, pathway analysis was per-
formed using the fruit fly (Drosophila melanogaster) library from the KEGG database [38]. The
hypergeometric test was chosen to be pathway analysis algorithm for the over representation
analysis and the relative betweenness centrality for pathway topology analysis.
The Metabolite Set Enrichment Analysis (MSEA) is a tool to test if there are some biologi-
cally meaningful groups (e.g., pathways) of metabolites that are significantly enriched. After
data processing and compound name mapping, enrichment analysis was performed using the
Overrepresentation Analysis (ORA) against a knowledge database, the Pathway-associated
metabolite sets library, which contains 99 metabolite sets based on normal metabolic path-
ways, in the Small Molecular Pathway Database (SMPDB) [39].
3. Results
Levels of 149 and 181 metabolites in the muscle at 24 and 48 hpi (hour post injection), respec-
tively, and those of 24 and 12 metabolites in the hepatopancreas at 24 and 48 hpi, respectively,
were found significantly different between the saline-injected (SAI) and CHH double-stranded
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RNA-injected (CHH DSI) animals (Procambarus clarkii). To give a comprehensive survey of
the effects of silencing CHH gene expression on tissue metabolism, all significantly changed
metabolites were analyzed using MetPA (Metabolic Pathway Analysis) and MSEA (Metabolite
Set Enrichment Analysis) with web-based resource (MetaboAnalyst, v. 4.0).
3.1 MetPA
Analysis with MetPA indicated that the following pathways were significantly affected by
silencing of CHH gene expression at 24 hpi in the muscle (Table 1 and S1 Table): Glyoxylate
and dicarboxylate metabolism, Nicotinate and nicotinamide metabolism, Alanine, aspartate
and glutamate metabolism, Pyruvate metabolism, and Nitrogen metabolism. At 48 hpi, only
Nicotinate and nicotinamide metabolism remained significantly affected (Table 1 and S1
Table).
In the hepatopancreas, silencing of CHH gene expression significantly impacted Pyruvate
metabolism and Glycolysis or gluconeogenesis at 24 hpi, and Glycine, serine and threonine
metabolism at 48 hpi (Table 2 and S2 Table).
3.2 MSEA
Analysis using MSEA showed that several Small Molecular Pathway Database (SMPDB)
metabolite sets were significantly affected in the muscle at 24 hpi (Table 3 and S3 Table),
including Ammonia recycling, Nicotinate and nicotinamide metabolism, Aspartate metabo-
lism, Pyruvate metabolism, Alanine metabolism, Glutamate metabolism, Purine metabolism,
Arginine and Proline metabolism, Glycine and serine metabolism, Warburg effect, and Citric
acid cycle (Table 3 and S3 Table). At 48 hpi, the metabolic groups that remained significantly
Table 1. KEGG metabolic pathways significantly impacted in the muscle of the crayfish Procambarus clarkii by silencing of CHH gene expression as revealed by
Metabolic Pathway Analysis.
Time point Pathway Totala Hitsb p-Valuec
24 hpi Glyoxylate and dicarboxylate metabolism 16 7 0.0019
Nicotinate and nicotinamide metabolism 9 5 0.0025
Alanine, aspartate and glutamate metabolism 23 7 0.019
Pyruvate metabolism 24 7 0.024
Nitrogen metabolism 7 3 0.047
48 hpi Nicotinate and nicotinamide metabolism 9 5 0.005
aTotal genes in the biological pathway.
bNumber of genes hit in the biological pathway.
cp-Value calculated from raw data.
https://doi.org/10.1371/journal.pone.0221745.t001
Table 2. KEGG metabolic pathways significantly impacted in the hepatopancreas of the crayfish Procambarus clarkii by silencing of CHH gene expression as
revealed by Metabolic Pathway Analysis.
Time point Pathway Totala Hitsb p-Valuec
24 hpi Pyruvate metabolism 24 3 0.010
Glycolysis or Gluconeogenesis 25 3 0.011
48 hpi Glycine, serine and threonine metabolism 25 2 0.019
aTotal genes in the biological pathway.
bNumber of genes hit in the biological pathway.
cp-Value calculated from raw data.
https://doi.org/10.1371/journal.pone.0221745.t002
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affected included Nicotinate and nicotinamide metabolism, Glycine and serine metabolism,
and Ammonia recycling (Table 3 and S3 Table).
In the hepatopancreas, MSEA analysis showed that Fatty acid biosynthesis was significantly
impacted at 24 hpi (Table 4 and S4 Table).
3.3 Changes in amino acid and nucleotide metabolic profiles
Combined results derived from analyses of MetPA and MSEA indicated that silencing of CHH
gene expression significantly affected metabolism of carbohydrates (in the muscle and hepato-
pancreas), nucleotides and amino acids (mainly in the muscle), and fatty acids (in the hepato-
pancreas). A comprehensive discussion on carbohydrate and energy metabolism in the muscle
and hepatopancreas has been reported previously [34]. Here, changes in the profile of metabo-
lites in amino acid and nucleotide metabolism will be described in details.
In the muscle at 24 hpi, levels of several amino acids, including alanine, arginine, aspartate,
glutamate, glutamine, proline and serine decreased significantly, while those of 5 amino acids
or related compounds, asparagine, anserine, histidine, histamine, and β-alanine, significantly
increased (Fig 1). At 48hpi, the changes were similar to those at 24 hpi, with aspartate no lon-
ger significantly decreased and anserine no longer significantly increased (Fig 1).
Table 3. SMPDB metabolite sets significantly impacted in the muscle of the crayfish Procambarus clarkii by silencing of CHH gene expression as revealed by Metab-
olite Set Enrichment Analysis.
Time point Pathway Totala Hitsb p-Valuec
24 hpi Ammonia Recycling 32 13 0.0002
Nicotinate and Nicotinamide Metabolism 37 14 0.0003
Aspartate Metabolism 35 12 0.002
Pyruvate Metabolism 48 14 0.005
Alanine Metabolism 17 7 0.006
Glutamate Metabolism 49 14 0.006
Purine Metabolism 74 18 0.012
Arginine and Proline Metabolism 53 14 0.013
Glycine and Serine Metabolism 59 15 0.015
Warburg Effect 58 14 0.029
Citric acid cycle 32 9 0.03
48 hpi Nicotinate and Nicotinamide Metabolism 37 14 0.002
Glycine and Serine Metabolism 59 19 0.003
Ammonia Recycling 32 12 0.005
aTotal genes in the biological pathway.
bNumber of genes hit in the biological pathway.
cp-Value calculated from raw data.
https://doi.org/10.1371/journal.pone.0221745.t003
Table 4. SMPDB metabolite sets significantly impacted in the hepatopancreas of the crayfish Procambarus clarkii
by silencing of CHH gene expression as revealed by Metabolite Set Enrichment Analysis.
Time point Pathway Totala Hitsb p-Valuec
24 hpi Fatty Acid Biosynthesis 35 3 0.045
aTotal genes in the biological pathway.
bNumber of genes hit in the biological pathway.
cp-Value calculated from raw data.
https://doi.org/10.1371/journal.pone.0221745.t004
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In response to silencing of CHH gene expression in the muscle at 24 hpi, metabolite levels
involved in nucleotide metabolism significantly decreased almost across the board, including
adenine, adenosine, ADP, AMP, ATP, GTP, guanosine, hypoxanthine, inosine, xanthine,
xanthosine, cytidine, cytosine, dCTP, dTTP, thymidine, uracil, urea and uridine (Fig 2). Simi-
lar trends of changes were observed at 48 hpi (Fig 2).
In the hepatopancreas, with regard to nucleotide metabolism only levels of thymine and
urea were significantly decreased at 24 hpi and no significant change was found at 48 hpi.
4. Discussion
In the present study, comprehensive analysis of the metabolite whose levels were significantly
changed by silencing CHH gene expression revealed that the effects were not limited to carbo-
hydrate and energy metabolism as previous studies had indicated [22, 33, 34]. Analysis of the
Fig 1. Amino acids and related compounds whose concentration significantly changed by silencing of CHH gene expression in the muscle of the crayfish
Procambarus clarkii at 24 and 48 hpi. White bar, saline-injected group (SAI); black bar, CHH double-stranded RNA-injected group (CHH DSI). �, p<0.05; ��, p<0.01;
���, p<0.001.
https://doi.org/10.1371/journal.pone.0221745.g001
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metabolite whose levels were significantly changed by silencing CHH gene expression revealed
that the effects were not limited to carbohydrate and energy metabolism as previous studies
had indicated. Thus, combined data derived from MetPA and MSEA revealed additionally
that, in the muscle nucleotide metabolism was severely reduced, likely due to a negatively
impacted pentose phosphate pathway (PPP), and amino acid metabolism significantly affected
that would likely result in slowing down protein synthesis, while in the hepatopancreas fatty
acid biosynthesis was significantly affected.
Specifically, in the muscle, one of the pathways significantly negatively affected at both 24
hpi and 48 hpi is Nicotinate and nicotinamide metabolism, which concerns the metabolism of
two nicotinamide coenzymes (NAD+ and NADP+) and has metabolically diverse ramification,
with levels of both coenzymes being significantly reduced (Table 1 and S1 Table). We have
suggested that low availability of NAD+ was central to the metabolic changes in the muscle in
response to silenced CHH gene expression, which led to reduced fluxes of glycolysis and TCA
Fig 2. Metabolites involved in nucleotide metabolism whose concentration significantly changed by silencing of CHH gene expression in the muscle of the
crayfish Procambarus clarkii. White bar, saline-injected group (SAI); black bar, CHH double-stranded RNA-injected group (CHH DSI). �, p<0.05; ��, p<0.01; ���,
p<0.001.
https://doi.org/10.1371/journal.pone.0221745.g002
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cycle and eventually to diminished ATP levels [34]. In the same vein, low availability of
NADP+ could reduce the flux of pentose phosphate pathway (PPP), resulting in lower levels of
two PPP metabolites, NADPH and ribose 5-phosphate, which have diverse metabolic func-
tions [41, 42]. NADPH is consumed in reductive reactions including the reduction of ribonu-
cleotides to deoxyribonucleotides, whereas ribose 5-phosphate, via PRPP (5-phosphoribosyl
1-pyrophosphate), is a precursor to nucleotide biosynthesis [43] (see Fig 3). Thus, a negatively
impacted PPP would, as a result of low NADP+ levels, decrease nucleotide biosynthesis, which
was clearly demonstrated by significantly lower levels of nucleotides across the board (Figs 2
and 3).
Another pathway that was significantly affected in the muscle by CHH gene silencing at
24 hpi is Pyruvate metabolism (Table 1 and S1 Table). Pyruvate sits at a site where several
metabolic pathways intersect. A significantly affected pyruvate metabolism is compatible with
the observations that glycolysis and TCA cycle were negatively impacted in the muscle when
CHH gene expression was silenced [34]. Pyruvate could also be used to directly form alanine
or converted via a TCA intermediate (α-ketoglutarate) to other non-essential amino acids
such as glutamate, glutamine, arginine, proline [44], whose levels were all decreased after
CHH gene expression was silenced (Figs 1 and 3). Moreover, a glycolytic intermediate
Fig 3. Metabolic profiles of the muscle of the crayfish Procambarus clarkii after CHH dsRNA treatment. Red rectangle: significantly decreased from saline-injected
levels at both 24 and 48 hpi; blue rectangle: significantly increased from saline-injected levels at both 24 and 48 hpi; yellow rectangle: significantly decreased from saline-
injected levels only at 24 hpi; green rectangle: significantly increased from saline-injected levels only at 24 hpi; gray rectangle: not detected. Dotted lines indicate multiple
metabolic steps are involved that are not individually specified. ADP: adenosine diphosphate, AMP: adenosine monophosphate, ATP: adenosine triphosphate, CDP:
cytidine diphosphate, dCTP: deoxycytidine triphosphate, Glucose 6-P: glucose 6-phosphate, GTP: guanosine triphosphate, IMP: inosine monophosphate, NAD+/
NADH: oxidized/reduced nicotinamide adenine dinucleotide, NADP+/NADPH: oxidized/reduced nicotinamide adenine dinucleotide phosphate, Ribose 5-P: ribose
5-phosphate; PRPP: phosphoribosyl pyrophosphate, UMP: uridine monophosphate.
https://doi.org/10.1371/journal.pone.0221745.g003
Metabolic regulation by crustacean hyperglycemic hormone
PLOS ONE | https://doi.org/10.1371/journal.pone.0221745 December 26, 2019 8 / 14
(3-phosphoglycerate) could serve as a precursor for the biosynthesis of serine [44], levels of
which were significantly decreased (Figs 1 and 3). Indeed, analyses with MetPA and MSEA
confirmed that Alanine, aspartate and glutamate metabolism and several amino acid metabo-
lite sets (Aspartate metabolism, Alanine metabolism, Glutamate metabolism, Arginine and
proline metabolism, Glycine and serine metabolism) was negatively affected (Tables 1 and 3,
S1 and S3 Tables). On the other hand, levels of several amino acids and related metabolites in
the muscle were increased after silencing CHH gene expression; these included those of aspar-
agine, anserine, histidine, histamine, and β-alanine (Fig 1). Aspartate and asparagine are two
of the amino acids that could be synthesized from a TCA intermediate (oxaloacetate) [44],
whose levels was shown to be significantly accumulated because of inhibition of the 3 NAD+-
dependent TCA reactions that carry isocitrate through to oxaloacetate due to low NAD+ levels
[34]. Thus, an increase in asparagine levels was likely a spillover from a TCA cycle thus inhib-
ited (Fig 3). In addition, increases in β-alanine, histidine, and anserine levels (Fig 1) are worth
mentioning. Carnosine (not detected) is a dipeptide, highly concentrated in the muscle and
brain, consists of β-alanine and histidine, and could be converted to anserine via methylation
of the histidine residue (Fig 3) [45]. Carnosine has been shown to be able to, among others,
scavenge and detoxify reactive oxygen species and reactive aldehyde derived from lipid peroxi-
dation [45, 46]. Thus, elevated levels of β-alanine, histidine, and anserine suggest that degrada-
tion (to β-alanine and histidine) and conversion (to anserine) from carnosine were enhanced
under silenced CHH gene expression and imply that CHH has protective roles for the muscle
cells by increasing carnosine levels via combination of β-alanine and histidine and conversion
from anserine. Finally, Glyoxylate and dicarboxylate metabolism, which was highly signifi-
cantly impacted by silenced CHH gene expression (see Table 1 and S1 Table), describes a vari-
ety of reactions involving glyoxylate or dicarboxylates that interconnect with several aspects of
cellular metabolism, including Pyruvate metabolism and TCA cycle, Glycine, serine and threo-
nine metabolism, Purine metabolism, Nitrogen metabolism that were also impacted as
revealed by MetPA and MSEA.
In the hepatopancreas, the effects of silencing CHH gene expression were comparatively
milder than in the muscle. Significantly affected pathways include Pyruvate metabolism and
Glycolysis or Gluconeogenesis, which are consistent with our previous suggestion that glycoly-
sis was inhibited and gluconeogenesis stimulated [34].
MSEA analysis of the metabolites, other than confirmed affected pathways as suggested by
MetPA, provided additional insights regarding the effects of silencing CHH gene expression.
Thus, in the muscle, MSEA analysis identified Warburg Effect as a metabolite set being signifi-
cantly negatively affected in response to CHH gene silencing at 24 hpi (see Table 3 and S3
Table). An invertebrate Warburg effect, characterized by up-regulation of several metabolic
pathways, including glycolysis, the pentose phosphate pathway, ribonucleotide biosynthesis,
glutaminolysis and amino acid biosynthesis, was observed in the tissues of the white spot syn-
drome virus (WSSV)-infected shrimps [47]. Based on the tissue responses (in the muscle) to
silencing of CHH gene expression, the metabolic profile of the Warburg effect induced by
WSSV infection is consistent with what would be expected when CHH release is greatly
enhanced. Indeed, infection of white spot syndrome virus enhanced a rapid and long-lasting
release of CHH into hemolymph [48]. Thus, the combined data support the notion that the
WSSV-induced Warburg effect is at least in part due to the metabolic effects of CHH released
by WSSV infection. In addition, MSEA also revealed that in the muscle Ammonia recycling,
which involves deamination of excess amino acids and purine nucleotides [44], was negatively
impacted (see Table 3 and S3 Table), which, combined with results showing significantly lower
levels of amino acids and nucleotides (Figs 1 and 2), indicated a metabolic status of low protein
and nucleic acid turnovers. Moreover, analysis with MSEA indicated that in the
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hepatopancreas fatty acid biosynthesis was significantly affected (Table 4 and and S4 Table).
Due to the limitation of the methodology employed by the present study, only water soluble
short-chained fatty acids (acetate, butyrate, caprate) were detected, whose levels decreased sig-
nificantly (S4 Table). The results obtained under silenced CHH gene expression, though only a
small sub-set of fatty acids were detected and quantified, are consistent with those from a pre-
vious study showing that CHH stimulated lipid mobilization from the storage tissues (e.g., the
hepatopancreas), releasing free fatty acids into hemolymph, to be used metabolically in the
consuming tissues [49].
5. Conclusion
In summary, the present study, combined with methods developed in a previous study [34],
established a metabolomics pipeline that includes an NMR-based detection and identification
of tissue metabolites and a web-based tool suite MetaboAnalyst allowing interpretation of
metabolomics data in the context of metabolic network. In conjunction with a dsRNA-based
gene silencing method [34], the metabolomics pipeline characterized the metabolic effect of
CHH on its target tissues as far more diverse than previously realized. In brief, CHH clearly
has differential effects on the 2 target tissues, with the muscle much more heavily regulated by
CHH. Whereas CHH is expected to stimulate glycolysis and lipolysis in the hepatopancreas, its
Fig 4. Proposed metabolic roles of CHH in the muscle and hepatopancreas.
https://doi.org/10.1371/journal.pone.0221745.g004
Metabolic regulation by crustacean hyperglycemic hormone
PLOS ONE | https://doi.org/10.1371/journal.pone.0221745 December 26, 2019 10 / 14
stimulatory effect on nicotinate and nicotinamide metabolism plays an important role in the
muscle coordinating stimulation of the fluxes of glycolysis, TCA cycle, and pentose phosphate
pathway, leading to increased ATP supply and elevated protein and nucleic acid turnovers.
Combining our data and previous ones [22, 28, 29, 31, 33, 34, 49, 50], a comprehensive scheme
of CHH roles in the 2 target tissues is proposed (Fig 4). Under conditions when its release
from the eyestalk ganglia into the hemolymph is stimulated [23, 24, 25, 26, 27, 48], CHH acts
on and differentially regulates its target tissues. Hence, while CHH stimulates glycogenolysis
in both target tissues, resulting in higher levels of glucose [28, 29, 30, 31, 50] that drives glyco-
lytic flux [22, 33], in the hepatopancreas, CHH additionally enhances lipolysis [49 and the
present study]. Glucose and free fatty acids are released into the hemolymph and taken up by
the muscle where they are further metabolized via glycolysis and TCA cycle, respectively, for
ATP production. In the muscle, central to the effects of CHH is a stimulated Nicotinate and
nicotinamide metabolism, which provides two nicotinamide coenzymes (NAD+ and NADP+)
that drive glycolysis and TCA cycle, and the pentose phosphate pathway, respectively [34 and
the present study], resulting in more ATP supply and higher protein and nucleic acid turnover.
Additionally, CHH may provide protective effects to the muscle by increasing carnosine levels.
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